208 related articles for article (PubMed ID: 2876744)
21. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years.
Kirwan J; Edwards A; Huitfeldt B; Thompson P; Currey H
Br J Rheumatol; 1993 Aug; 32(8):729-33. PubMed ID: 8102305
[TBL] [Abstract][Full Text] [Related]
22. Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
Savastano M; Marioni G; Bernini G; Punzi L
Acta Otolaryngol; 2005 Jun; 125(6):671-3. PubMed ID: 16076720
[TBL] [Abstract][Full Text] [Related]
23. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.
Clegg DO; Reda DJ; Weisman MH; Blackburn WD; Cush JJ; Cannon GW; Mahowald ML; Schumacher HR; Taylor T; Budiman-Mak E; Cohen MR; Vasey FB; Luggen ME; Mejias E; Silverman SL; Makkena R; Alepa FP; Buxbaum J; Haakenson CM; Ward RH; Manaster BJ; Anderson RJ; Ward JR; Henderson WG
Arthritis Rheum; 1996 Dec; 39(12):2004-12. PubMed ID: 8961905
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
van der Heijde D; Braun J; Dougados M; Sieper J; Pedersen R; Szumski A; Koenig AS
Rheumatology (Oxford); 2012 Oct; 51(10):1894-905. PubMed ID: 22772319
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological treatment of ankylosing spondylitis: a systematic review.
Boulos P; Dougados M; Macleod SM; Hunsche E
Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.
Braun J; Zochling J; Baraliakos X; Alten R; Burmester G; Grasedyck K; Brandt J; Haibel H; Hammer M; Krause A; Mielke F; Tony HP; Ebner W; Gömör B; Hermann J; Zeidler H; Beck E; Baumgaertner M; Sieper J
Ann Rheum Dis; 2006 Sep; 65(9):1147-53. PubMed ID: 16606646
[TBL] [Abstract][Full Text] [Related]
27. Sulphasalazine in the treatment of children with chronic arthritis.
Huang JL; Chen LC
Clin Rheumatol; 1998; 17(5):359-63. PubMed ID: 9805178
[TBL] [Abstract][Full Text] [Related]
28. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
Clegg DO; Reda DJ; Abdellatif M
Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027
[TBL] [Abstract][Full Text] [Related]
29. Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia.
Damjanov N; Shehhi WA; Huang F; Kotak S; Burgos-Vargas R; Shirazy K; Bananis E; Szumski A; Llamado LJ; Mahgoub E
Rheumatol Int; 2016 May; 36(5):643-51. PubMed ID: 26968844
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis.
Khanna Sharma S; Kadiyala V; Naidu G; Dhir V
Int J Rheum Dis; 2018 Jan; 21(1):308-314. PubMed ID: 28737251
[TBL] [Abstract][Full Text] [Related]
31. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.
Li Q; Li L; Bi L; Xiao C; Lin Z; Cao S; Liao Z; Gu J
Trials; 2016 Jul; 17(1):337. PubMed ID: 27449221
[TBL] [Abstract][Full Text] [Related]
32. Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R
Ann Rheum Dis; 1988 Jan; 47(1):10-4. PubMed ID: 2894204
[TBL] [Abstract][Full Text] [Related]
33. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
Burgos-Vargas R; Vázquez-Mellado J; Pacheco-Tena C; Hernández-Garduño A; Goycochea-Robles MV
Ann Rheum Dis; 2002 Oct; 61(10):941-2. PubMed ID: 12228171
[No Abstract] [Full Text] [Related]
34. Meta-analysis of sulfasalazine in ankylosing spondylitis.
Ferraz MB; Tugwell P; Goldsmith CH; Atra E
J Rheumatol; 1990 Nov; 17(11):1482-6. PubMed ID: 1980310
[TBL] [Abstract][Full Text] [Related]
35. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial.
Egsmose C; Hansen TM; Andersen LS; Beier JM; Christensen L; Ejstrup L; Peters ND; van der Heijde DM
Ann Rheum Dis; 1997 Jan; 56(1):32-6. PubMed ID: 9059138
[TBL] [Abstract][Full Text] [Related]
36. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study.
Biasi D; Carletto A; Caramaschi P; Pacor ML; Maleknia T; Bambara LM
Clin Rheumatol; 2000; 19(2):114-7. PubMed ID: 10791621
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of sulphasalazine in the treatment of spondyloarthropathies.
Dougados M; Maetzel A; Mijiyawa M; Amor B
Ann Rheum Dis; 1992 Aug; 51(8):955-8. PubMed ID: 1358038
[TBL] [Abstract][Full Text] [Related]
39. [Sulfasalazine in rheumatology].
Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
[TBL] [Abstract][Full Text] [Related]
40. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H
Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
